Form 8-K - Current report:
SEC Accession No. 0001493152-24-004502
Filing Date
2024-01-31
Accepted
2024-01-31 16:20:41
Documents
14
Period of Report
2024-01-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39885
  Complete submission text file 0001493152-24-004502.txt   207310

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sigy-20240131.xsd EX-101.SCH 3042
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sigy-20240131_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sigy-20240131_pre.xml EX-101.PRE 22377
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3311
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 24583194
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)